Evidence map›Paper›PMID 38359063›Full record

ArticlePloS one2024

Antioxidant and antiproliferative effect of a glycosaminoglycan extract from Rapana venosa marine snail.

Alexandra Gaspar-Pintiliescu, Laura M Stefan, Elena Mihai, Catalina Sanda, Vasile S Manoiu, Daniela Berger, Oana Craciunescu

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Alexandra Gaspar-PintiliescuDepartment of Cellular and Molecular Biology, National Institute of Research and Development for Biological Sciences, Bucharest, Romania.
Laura M StefanDepartment of Cellular and Molecular Biology, National Institute of Research and Development for Biological Sciences, Bucharest, Romania.ORCID 0000-0003-4943-5227
Elena MihaiDepartment of Cellular and Molecular Biology, National Institute of Research and Development for Biological Sciences, Bucharest, Romania.
Catalina SandaDepartment of Cellular and Molecular Biology, National Institute of Research and Development for Biological Sciences, Bucharest, Romania.
Vasile S ManoiuDepartment of Cellular and Molecular Biology, National Institute of Research and Development for Biological Sciences, Bucharest, Romania.
Daniela BergerFaculty of Chemical Engineering and Biotechnologies, University "Politehnica" of Bucharest, Bucharest, Romania.ORCID 0000-0002-7829-7540
Oana CraciunescuDepartment of Cellular and Molecular Biology, National Institute of Research and Development for Biological Sciences, Bucharest, Romania.
National Institute of Research and Development for Biological Sciences · ROUniversitatea Națională de Știință și Tehnologie Politehnica București · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marine glycosaminoglycans (GAG) isolated from different invertebrates, such as molluscs, starfish or jellyfish, have been described as unique molecules with important pharmacological applications. Scarce information is available on GAG extract from Rapana venosa marine snail. The aim of this study was to isolate a GAG extract from R. venosa marine snail and to investigate its physicochemical, antioxidant and antiproliferative properties for further biomedical use. The morphology, chemical and elemental composition of the extract were established as well as the sulfate content and N- to O-sulfation ratio. Fourier transform infrared (FTIR) spectra indicated that GAG extract presented similar structural characteristics to bovine heparan sulfate and chondroitin sulfate. The pattern of extract migration in agarose gel electrophoresis and specific digestion with chondroitinase ABC and heparinase III indicated the presence of a mixture of chondroitin sulfate-type GAG, as main component, and heparan sulfate-type GAG. Free radical scavenging and ferric ion reducing assays showed that GAG extract had high antioxidant activity, which slightly decreased after enzymatic treatment. In vitro MTT and Live/Dead assays showed that GAG extract had the ability to inhibit cell proliferation in human Hep-2 cell cultures, at cytocompatible concentrations in normal NCTC clone L929 fibroblasts. This capacity decreased after enzymatic digestion, in accordance to the antioxidant activity of the products. Tumoral cell migration was also inhibited by GAG extract and its digestion products. Overall, GAG extract from R. venosa marine snail exhibited antioxidant and antiproliferative activities, suggesting its potential use as novel bioactive compound for biomedical applications.

Indexed as

Chondroitin SulfatesGlycosaminoglycansAnimalsAntioxidantsCattleHeparan SulfateHumansSnailsAntioxidantsChondroitin SulfatesGlycosaminoglycansHeparan Sulfate

Identifiers

PMID38359063
PMCPMC10868805
OpenAlexW4391839127

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.